nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipivefrin—ADRA1A—G alpha (12/13) signalling events—FGD1—nicotine dependence	0.0255	0.0255	CbGpPWpGaD
Dipivefrin—ADRA2B—Monoamine GPCRs—DRD2—nicotine dependence	0.0234	0.0234	CbGpPWpGaD
Dipivefrin—ADRB2—Monoamine GPCRs—DRD2—nicotine dependence	0.0231	0.0231	CbGpPWpGaD
Dipivefrin—ADRA2C—Monoamine GPCRs—DRD2—nicotine dependence	0.0219	0.0219	CbGpPWpGaD
Dipivefrin—ACHE—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.0206	0.0206	CbGpPWpGaD
Dipivefrin—ADRA2B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0197	0.0197	CbGpPWpGaD
Dipivefrin—ACHE—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.0195	0.0195	CbGpPWpGaD
Dipivefrin—ADRB2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0194	0.0194	CbGpPWpGaD
Dipivefrin—ADRA1A—Monoamine GPCRs—DRD2—nicotine dependence	0.0191	0.0191	CbGpPWpGaD
Dipivefrin—ADRA2C—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0184	0.0184	CbGpPWpGaD
Dipivefrin—BCHE—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.0184	0.0184	CbGpPWpGaD
Dipivefrin—ADRA2A—Monoamine GPCRs—DRD2—nicotine dependence	0.0178	0.0178	CbGpPWpGaD
Dipivefrin—BCHE—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.0174	0.0174	CbGpPWpGaD
Dipivefrin—ADRA1A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0161	0.0161	CbGpPWpGaD
Dipivefrin—ADRA2B—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.016	0.016	CbGpPWpGaD
Dipivefrin—ACHE—Neuronal System—CHRNB3—nicotine dependence	0.0158	0.0158	CbGpPWpGaD
Dipivefrin—ACHE—Neuronal System—CHRNA6—nicotine dependence	0.015	0.015	CbGpPWpGaD
Dipivefrin—ADRA2A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0149	0.0149	CbGpPWpGaD
Dipivefrin—ADRA2C—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0149	0.0149	CbGpPWpGaD
Dipivefrin—ACHE—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.0141	0.0141	CbGpPWpGaD
Dipivefrin—BCHE—Neuronal System—CHRNB3—nicotine dependence	0.0141	0.0141	CbGpPWpGaD
Dipivefrin—ACHE—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.0135	0.0135	CbGpPWpGaD
Dipivefrin—BCHE—Neuronal System—CHRNA6—nicotine dependence	0.0133	0.0133	CbGpPWpGaD
Dipivefrin—BCHE—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.0126	0.0126	CbGpPWpGaD
Dipivefrin—ACHE—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.0126	0.0126	CbGpPWpGaD
Dipivefrin—ADRA2A—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0121	0.0121	CbGpPWpGaD
Dipivefrin—BCHE—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.0121	0.0121	CbGpPWpGaD
Dipivefrin—BCHE—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.0112	0.0112	CbGpPWpGaD
Dipivefrin—ACHE—Neuronal System—GABRA4—nicotine dependence	0.0108	0.0108	CbGpPWpGaD
Dipivefrin—ACHE—Neuronal System—CHRNB4—nicotine dependence	0.0104	0.0104	CbGpPWpGaD
Dipivefrin—ACHE—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.0103	0.0103	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—TAS2R16—nicotine dependence	0.00967	0.00967	CbGpPWpGaD
Dipivefrin—BCHE—Neuronal System—GABRA4—nicotine dependence	0.00964	0.00964	CbGpPWpGaD
Dipivefrin—ACHE—Neuronal System—CHRNA5—nicotine dependence	0.00963	0.00963	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00954	0.00954	CbGpPWpGaD
Dipivefrin—BCHE—Neuronal System—CHRNB4—nicotine dependence	0.00925	0.00925	CbGpPWpGaD
Dipivefrin—BCHE—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00914	0.00914	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—TAS2R16—nicotine dependence	0.00903	0.00903	CbGpPWpGaD
Dipivefrin—ACHE—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00902	0.00902	CbGpPWpGaD
Dipivefrin—BCHE—Neuronal System—CHRNA5—nicotine dependence	0.0086	0.0086	CbGpPWpGaD
Dipivefrin—ACHE—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00819	0.00819	CbGpPWpGaD
Dipivefrin—BCHE—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00805	0.00805	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00789	0.00789	CbGpPWpGaD
Dipivefrin—ACHE—Neuronal System—CHRNA3—nicotine dependence	0.00785	0.00785	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00733	0.00733	CbGpPWpGaD
Dipivefrin—BCHE—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00731	0.00731	CbGpPWpGaD
Dipivefrin—BCHE—Neuronal System—CHRNA3—nicotine dependence	0.00701	0.00701	CbGpPWpGaD
Dipivefrin—ACHE—Neuronal System—CHRNB2—nicotine dependence	0.00691	0.00691	CbGpPWpGaD
Dipivefrin—ADRA2B—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00673	0.00673	CbGpPWpGaD
Dipivefrin—ADRA2C—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00629	0.00629	CbGpPWpGaD
Dipivefrin—ACHE—Neuronal System—CHRNA4—nicotine dependence	0.00628	0.00628	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00625	0.00625	CbGpPWpGaD
Dipivefrin—BCHE—Neuronal System—CHRNB2—nicotine dependence	0.00617	0.00617	CbGpPWpGaD
Dipivefrin—ADRB2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00617	0.00617	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00583	0.00583	CbGpPWpGaD
Dipivefrin—BCHE—Neuronal System—CHRNA4—nicotine dependence	0.0056	0.0056	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00546	0.00546	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00539	0.00539	CbGpPWpGaD
Dipivefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00535	0.00535	CbGpPWpGaD
Dipivefrin—ADRB2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00528	0.00528	CbGpPWpGaD
Dipivefrin—ADRA2A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00511	0.00511	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0051	0.0051	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.0051	0.0051	CbGpPWpGaD
Dipivefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.005	0.005	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00496	0.00496	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—TAS2R16—nicotine dependence	0.0049	0.0049	CbGpPWpGaD
Dipivefrin—ADRA2B—G alpha (i) signalling events—DRD2—nicotine dependence	0.00487	0.00487	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00474	0.00474	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.00463	0.00463	CbGpPWpGaD
Dipivefrin—ADRA2C—G alpha (i) signalling events—DRD2—nicotine dependence	0.00455	0.00455	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00452	0.00452	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00446	0.00446	CbGpPWpGaD
Dipivefrin—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00446	0.00446	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00437	0.00437	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—FGD1—nicotine dependence	0.00429	0.00429	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—FGD1—nicotine dependence	0.00423	0.00423	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00422	0.00422	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00414	0.00414	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—OPRM1—nicotine dependence	0.00408	0.00408	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00406	0.00406	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00405	0.00405	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—OPRM1—nicotine dependence	0.00402	0.00402	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—FGD1—nicotine dependence	0.004	0.004	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—FGD1—nicotine dependence	0.00389	0.00389	CbGpPWpGaD
Dipivefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00387	0.00387	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—FGD1—nicotine dependence	0.00384	0.00384	CbGpPWpGaD
Dipivefrin—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00382	0.00382	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—OPRM1—nicotine dependence	0.00381	0.00381	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00376	0.00376	CbGpPWpGaD
Dipivefrin—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.00369	0.00369	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00369	0.00369	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—FGD1—nicotine dependence	0.00364	0.00364	CbGpPWpGaD
Dipivefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00361	0.00361	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.0035	0.0035	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00343	0.00343	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.00333	0.00333	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.00325	0.00325	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	0.00318	0.00318	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00316	0.00316	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	0.00309	0.00309	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	0.00295	0.00295	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—DRD2—nicotine dependence	0.00295	0.00295	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00294	0.00294	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—TAS2R16—nicotine dependence	0.00293	0.00293	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—DRD2—nicotine dependence	0.00291	0.00291	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—TAS2R16—nicotine dependence	0.00289	0.00289	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—DRD2—nicotine dependence	0.00275	0.00275	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—TAS2R16—nicotine dependence	0.00274	0.00274	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—CYP2A7—nicotine dependence	0.00272	0.00272	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—CYP2A7—nicotine dependence	0.00243	0.00243	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	0.00241	0.00241	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	0.00239	0.00239	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.0023	0.0023	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—FGD1—nicotine dependence	0.0023	0.0023	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—OPRM1—nicotine dependence	0.00227	0.00227	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—FGD1—nicotine dependence	0.00227	0.00227	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	0.00224	0.00224	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	0.00222	0.00222	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—OPRM1—nicotine dependence	0.00215	0.00215	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—FGD1—nicotine dependence	0.00215	0.00215	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—CYP2A7—nicotine dependence	0.00211	0.00211	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—OPRM1—nicotine dependence	0.00209	0.00209	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—OPRM1—nicotine dependence	0.00206	0.00206	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—AKR1B10—nicotine dependence	0.00203	0.00203	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—AKR1B10—nicotine dependence	0.00201	0.00201	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—OPRM1—nicotine dependence	0.00195	0.00195	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—AKR1B10—nicotine dependence	0.0019	0.0019	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	0.00188	0.00188	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	0.00188	0.00188	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.00175	0.00175	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	0.00174	0.00174	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CYP2A7—nicotine dependence	0.00171	0.00171	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	0.00171	0.00171	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—DRD2—nicotine dependence	0.00166	0.00166	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	0.00166	0.00166	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—DRD2—nicotine dependence	0.00164	0.00164	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	0.00159	0.00159	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—DRD2—nicotine dependence	0.00156	0.00156	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	0.00154	0.00154	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—DRD2—nicotine dependence	0.00151	0.00151	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—DRD2—nicotine dependence	0.00149	0.00149	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—WASF2—nicotine dependence	0.00143	0.00143	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—WASF2—nicotine dependence	0.00141	0.00141	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—DRD2—nicotine dependence	0.00141	0.00141	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—WASF1—nicotine dependence	0.00137	0.00137	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	0.00136	0.00136	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—WASF1—nicotine dependence	0.00135	0.00135	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—WASF2—nicotine dependence	0.00134	0.00134	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—WASF1—nicotine dependence	0.00128	0.00128	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	0.00126	0.00126	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—OPRM1—nicotine dependence	0.00124	0.00124	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	0.00123	0.00123	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—OPRM1—nicotine dependence	0.00122	0.00122	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	0.00117	0.00117	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—OPRM1—nicotine dependence	0.00115	0.00115	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	0.00115	0.00115	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	0.00112	0.00112	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	0.00109	0.00109	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	0.00104	0.00104	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	0.00101	0.00101	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	0.000937	0.000937	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—DRD2—nicotine dependence	0.000893	0.000893	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—DRD2—nicotine dependence	0.000882	0.000882	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—DRD2—nicotine dependence	0.000834	0.000834	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	0.000729	0.000729	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	0.000678	0.000678	CbGpPWpGaD
